Ivabradine Hydrochloride API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Corlanor, Procoralan
Category: Active Pharmaceutical Ingredient
Ivabradine hydrochloride is an If-channel blocker that slows the heart rate, used in heart failure and stable angina. Formulators, CDMOs and R&D teams source the API.
Manufacture or export Ivabradine Hydrochloride API? List it or send an offer →
Product Description:
Ivabradine selectively blocks the If ('funny') current in the heart's sinus node, which slows the heart rate without lowering blood pressure or the force of contraction. It is approved for stable symptomatic chronic heart failure with reduced ejection fraction in adults and for paediatric heart failure due to dilated cardiomyopathy, as defined in the US label; in the EU it is also approved for symptomatic chronic stable angina (reference brand: Corlanor, Procoralan).
Specification at a glance
| Traded form | Hydrochloride of the (S)-enantiomer; base CAS 155974-00-8; marked polymorphism. |
|---|---|
| CAS number | 148849-67-6 |
| Molecular formula | C27H36N2O5 · HCl |
| Molecular weight | 505.05 g/mol (hydrochloride); 468.59 g/mol base |
| Pharmacopoeia | No Ph. Eur. monograph at the time of EU generic assessments (EMA, Ivabradine Accord); current Ph. Eur., USP and other pharmacopoeia status unverified. Supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 10 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Generics/biosimilars on the market (Aug 2024). European Union: No confirmed date.
Handling and quality points
Ivabradine hydrochloride shows marked polymorphism, with seven crystalline forms reported in one EU assessment, and several forms are patent-protected, so the form must be fixed in the specification and confirmed by XRPD. It is a single (S)-enantiomer, with the (R)-isomer controlled as an impurity. Regulators expect an ICH M7 assessment of potentially mutagenic impurities and a nitrosamine risk assessment, as the molecule contains a tertiary amine.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Ivabradine Hydrochloride API — third party manufacturing & bulk supply
Ivabradine Hydrochloride API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ivabradine Hydrochloride API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ivabradine Hydrochloride API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ivabradine Hydrochloride API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Ask for a GMP certificate, specification and CoA, and an EU ASMF or US DMF letter of access for your filing. Polymorph data, chiral purity results, the mutagenic impurity and nitrosamine assessments and stability data are also routine.
Several forms have been patented, and EU generic dossiers have used different ones; one EMA assessment describes seven crystalline forms, with the delta-d form chosen for development. Pick a form your formulation and patent advisers accept, then make sure the supplier controls it in the API specification and shows it stays stable over shelf life.
Yes. PharmaTradz connects licensed manufacturers, CDMOs and R&D teams with GMP-compliant ivabradine hydrochloride makers after a first review of their documents. We keep your details private until both sides agree to talk.
Related Products
Baricitinib API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Olumiant
View DetailsFerric Derisomaltose API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Monoferric, Monofer
View DetailsFerric Carboxymaltose API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Injectafer, Ferinject
View DetailsTrabectedin API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Yondelis
View DetailsRiociguat API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Adempas
View DetailsAcalabrutinib API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Calquence
View DetailsFerumoxytol API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Feraheme, Rienso
View DetailsOsimertinib Mesylate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Tagrisso
View DetailsUsually answered within 48 hours | GMP documents shared before you commit